Cargando…
Hereditary leiomyomatosis and renal cell cancer syndrome – case report and review of the literature
Hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC) is an exceptionally rare autosomal dominant condition caused by a germline heterozygous mutation of the fumarate hydratase gene. It manifests as multiple piloleiomyomas, associated with numerous, early-onset uterine leiomyomas in femal...
Autores principales: | Popa, Liliana Gabriela, Lutuc, Raluca Silvia, Mihai, Mara Mădălina, Ahmed Salem, Irina, Negoiţă, Silvius Ioan, Giurcăneanu, Călin, Fica, Simona Vasilica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864305/ https://www.ncbi.nlm.nih.gov/pubmed/33544811 http://dx.doi.org/10.47162/RJME.61.2.29 |
Ejemplares similares
-
The immunoexpression of epidermal growth factor receptor in cutaneous squamous cell carcinoma
por: Nichita, Mirela Marcela, et al.
Publicado: (2021) -
Hereditary leiomyomatosis and renal cell carcinoma
por: Schmidt, Laura S, et al.
Publicado: (2014) -
Hereditary Leiomyomatosis and Renal Cell Cancer
por: HANSEN, Anders Würgler, et al.
Publicado: (2020) -
Nanosystems for Improved Targeted Therapies in Melanoma
por: Beiu, Cristina, et al.
Publicado: (2020) -
How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?
por: Martin, Carmen Sorina, et al.
Publicado: (2022)